OTCMKTS:FCPG - First China Pharmaceutical Group Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$0.0010
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average Volume15,858 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
First China Pharmaceutical Group, Inc. operates through its wholly owned subsidiary Kun Ming Xin Yuan Tang Pharmacies Co. Ltd. (XYT) is engaged in drug logistics and distribution in Yunnan Province, China through drug stores, medical clinics and hospitals. XYT is a provincial pharmaceutical distributor that offers approximately 5,000 drugs, of which approximately 1,000 are over-the-counter drugs, approximately 1,000 are prescription drugs, approximately 2,000 are prepared Chinese medicines and approximately 1,000 are supplements. The Company's short term objective is to broaden its product line from 5,000 products to 30,000 and include significantly more Western medicines as well as traditional Chinese drugs and herbs. By expanding its product line six-fold and offering products at a lower price than major competitors, the Company expects to be able to become its customers' primary distributor, supplying more than 80% of the pharmaceutical products they require.

Receive FCPG News and Ratings via Email

Sign-up to receive the latest news and ratings for FCPG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:FCPG
CUSIP31948N109
Phone+86-852-21381668

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

First China Pharmaceutical Group (OTCMKTS:FCPG) Frequently Asked Questions

What is First China Pharmaceutical Group's stock symbol?

First China Pharmaceutical Group trades on the OTCMKTS under the ticker symbol "FCPG."

Has First China Pharmaceutical Group been receiving favorable news coverage?

News stories about FCPG stock have been trending somewhat negative this week, InfoTrie reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. First China Pharmaceutical Group earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next several days.

How do I buy shares of First China Pharmaceutical Group?

Shares of FCPG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is First China Pharmaceutical Group's official website?

The official website for First China Pharmaceutical Group is http://www.firstchinapharma.com/.

How can I contact First China Pharmaceutical Group?

First China Pharmaceutical Group's mailing address is Number 504, West Ren Min Road, KUNMING, YUN 650000, China. The company can be reached via phone at +86-852-21381668.


MarketBeat Community Rating for First China Pharmaceutical Group (OTCMKTS FCPG)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  72
MarketBeat's community ratings are surveys of what our community members think about First China Pharmaceutical Group and other stocks. Vote "Outperform" if you believe FCPG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FCPG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/26/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel